GeorgePaikKimMD

Oncology • Gainesville, FL

Physician

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
1600 SW Archer Rd
Gainesville, FL 32610
Phone+1 352-273-7832

Fax+1 352-273-7849
Is this information wrong?

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1997
University of Vermont College of MedicineClass of 1994

Certifications & Licensure

FL State Medical License 2002 - 2026
TX State Medical License 2023 - 2025
DC State Medical License 2018 - 2022
MD State Medical License 1997 - 2002
American Board of Internal Medicine Medical Oncology

Clinical Trials

Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) Start of enrollment: 2005 Apr 01
Completed
Phase 2
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer Start of enrollment: 2004 Dec 01
Completed
Phase 2
Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2005 Jul 01
Completed
Phase 2
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer Start of enrollment: 2005 Jun 01
Completed
Phase 2
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer Start of enrollment: 2009 Mar 01
Completed
Phase 2
Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery Start of enrollment: 2009 Jun 01
Completed
Phase 2
Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction Start of enrollment: 2013 Aug 23
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

77 citations
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Colin D. Weekes, Laetitia E. Lamberts, Mitesh J. Borad, Johannes Voortman, Robert R. McWilliams
Molecular Cancer Therapeutics. 2016-03-01
46 citations
Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant ...
F. Sinicrope, Nathan R. Foster, Harry H. Yoon, Thomas C. Smyrk, George P. Kim
Journal of Clinical Oncology. 2012-02-01
257 citations
Prognostic and Predictive Roles of High-Degree Microsatellite Instability in Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Proj...
George P. Kim, Linda H. Colangelo, H. Samuel Wieand, Soonmyung Paik, Ilan R. Kirsch
Journal of Clinical Oncology. 2007-03-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Cleveland Clinic Indian River HospitalVero Beach, Florida
UF Health Shands HospitalGainesville, Florida